Matches in Wikidata for { <http://www.wikidata.org/entity/Q84782451> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q84782451 description "article scientifique publié en 2011" @default.
- Q84782451 description "artículu científicu espublizáu n'agostu de 2011" @default.
- Q84782451 description "im August 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q84782451 description "scientific article published on 17 August 2011" @default.
- Q84782451 description "wetenschappelijk artikel" @default.
- Q84782451 description "наукова стаття, опублікована в серпні 2011" @default.
- Q84782451 name "Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate" @default.
- Q84782451 name "Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate" @default.
- Q84782451 type Item @default.
- Q84782451 label "Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate" @default.
- Q84782451 label "Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate" @default.
- Q84782451 prefLabel "Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate" @default.
- Q84782451 prefLabel "Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate" @default.
- Q84782451 P1433 Q84782451-C5E310DB-D188-4BAC-9A2C-248773E3434B @default.
- Q84782451 P1476 Q84782451-07AFDB18-EACE-456B-B5A4-04CEC7813D2D @default.
- Q84782451 P2093 Q84782451-B81A8992-5EB7-42C7-9C05-E3A51A3A36C3 @default.
- Q84782451 P2093 Q84782451-BA058F4D-13A5-4754-A12E-3CE4F4BA69C3 @default.
- Q84782451 P2093 Q84782451-E593DEFD-4CE3-4AFC-9F2B-7B1C4927740C @default.
- Q84782451 P2093 Q84782451-E699886D-9295-483E-8278-1F35BCFD698E @default.
- Q84782451 P304 Q84782451-533D12F1-0143-41C0-9E48-4F3370F01E4C @default.
- Q84782451 P31 Q84782451-310EAACC-BB83-4BF9-A8C2-60315FBEF90B @default.
- Q84782451 P356 Q84782451-20F7617B-C1D4-4EE3-9204-A3A772276714 @default.
- Q84782451 P433 Q84782451-BF73CCD7-11D9-421C-863D-BEB460434EF9 @default.
- Q84782451 P478 Q84782451-90B49E13-CBF0-405F-969C-0E30F5C90782 @default.
- Q84782451 P577 Q84782451-82A879A1-5C73-4CB9-BE75-AA9FD338F0D1 @default.
- Q84782451 P698 Q84782451-79B9AB51-6E9F-40ED-B67B-159E4F483A26 @default.
- Q84782451 P356 J.CLINTHERA.2011.07.012 @default.
- Q84782451 P698 21849210 @default.
- Q84782451 P1433 Q15716601 @default.
- Q84782451 P1476 "Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate" @default.
- Q84782451 P2093 "Chi-Feng Hsieh" @default.
- Q84782451 P2093 "Pei-Yu Lu" @default.
- Q84782451 P2093 "Weng-Foung Huang" @default.
- Q84782451 P2093 "Yi-Wen Tsai" @default.
- Q84782451 P304 "1173-1179" @default.
- Q84782451 P31 Q13442814 @default.
- Q84782451 P356 "10.1016/J.CLINTHERA.2011.07.012" @default.
- Q84782451 P433 "9" @default.
- Q84782451 P478 "33" @default.
- Q84782451 P577 "2011-08-17T00:00:00Z" @default.
- Q84782451 P698 "21849210" @default.